FDA Investigator Virginia L Meeks

Virginia L Meeks has conducted inspections on 44 sites in 1 countries as of 28 Apr 2008. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
44
Last Inspection Date:
28 Apr 2008
Investigator Role:
FDA Investigator
Redica ID:
100002168
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Virginia L Meeks:
Aaron J Fox, Bill Tacket, Jr, CDR Ileana Barreto Pettit, Christie A Soto, Christos G Tsingelis, Courtney A Gilbert, Craig A Garmendia, Darcy L Webber, Daryl A Dewoskin, David P King, Dillard H Woody, Jr, Dionne D Arline, Dr. Ralph M Bernstein, PhD, Ernest A Clausnitzer, Figarole, Frederic W French, III, Gene R Gunn, Gerardo Z Vazquez, Holly M Scott, James H Robinson, Jennifer A Robinson, Jennifer D Hollstrom, Jennifer L Huntington, Jennifer Lalama, Jessica L Pressley, Joanne E King, Jolanna A Norton, Jose R Rodriguez, Joshua J Silvestri, Karen G Hirshfield, Kayla V Sprague, Keith A Schwartz, Kelly I Anderson, Kristy E Zuroski, Ladislav Kermet, Laura B Kennedy, LCDR Michael H Tollon, Leon L Crawley, Lesley K Satterwhite, Leslie A Cartmill, Leslie A Jackanicz, Lillian Mcolon Mcknight, LT Daveta L Bailey, LT Kimberly M Hull, Lundy H Patrick, Mark Sassaman, Marvin D Jones, Megan T Ziegler, Meghan Murphy, Melanie G Warzala, Melanie W Pishnery, Miguel A Martinez Perez, Mihaly S Ligmond, Mizanne E Lewis, Nicolas Riveratorres, Nicole E Knowlton, Ormond, Paul L Figarole, Jr, Paula J Perry, Ravindra K Kaallwal, Richard K Vogel, Robert C Steyert, Rodney W Lenger, Salvatore N Randazzo, Samantha J Bradley, Scott T Ballard, Shari H Shambaugh, Sheirly J Reyes, Steven D Dittert, Suzanne N Vallez, Traci M Armand, Zada L Giles

Virginia L Meeks's Documents

Publish Date Document Type Title
May, 2002 FDA 483 Newco Pharm LLC - Form 483, 2002-05-20
December, 2002 FDA 483 Response Activ Group, Inc - Form 483R, 2003-01-08
August, 2004 FDA 483 Melissa Alsina, MD - Form 483, 2004-08-25
July, 2003 EIR Libi Labs, Inc. - EIR, 2003-07-29
March, 2002 FDA 483 Newco Pharm LLC - Form 483, 2002-03-11
November, 2002 FDA 483 Newco Pharm LLC - Form 483, 2002-11-12
December, 2002 FDA 483 Activ Group, Inc - Form 483, 2002-12-03
February, 2003 EIR Michael R. Piazza, M.D. - EIR, 2003-02-28
August, 2004 EIR Melissa Alsina, MD - EIR, 2004-08-25
February, 2001 EIR Jerry M Herron, Md/Clin Inv - EIR, 2001-02-01
February, 2003 FDA 483 Michael R. Piazza, M.D. - Form 483, 2003-02-28
May, 2004 FDA 483 Apheresis Technologies, Inc. - Form 483, 2004-05-24
July, 2003 FDA 483 Response Libi Labs, Inc. - Form 483R, 2003-10-07
October, 2003 FDA 483 Newco Pharm LLC - Form 483, 2003-10-16
May, 2008 FDA 483 Coast Quality Pharmacy, LLC dba Anazao Health - Form 483, 2008-05-21
July, 2003 FDA 483 Libi Labs, Inc. - Form 483, 2003-07-18

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more